Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.
暂无分享,去创建一个
I. Bernstein | S. Heimfeld | C. Turtle | S. Riddell | J. Gutman | C. Delaney | T. Manley
[1] J. Wagner,et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. , 2009, Blood.
[2] W. Leisenring,et al. Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] J. Wagner,et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. , 2009, Blood.
[4] J. Wagner,et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Jeff E. Mold,et al. Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero , 2008, Science.
[6] I. Bernstein,et al. Notch-Mediated Expansion of Human Cord Blood Progenitor Cells Results in Rapid Myeloid Reconstitution in Vivo Following Myeloablative Cord Blood Transplantation , 2008 .
[7] W. Leisenring,et al. Decreased Relapse Rates without Excessive Transplant Related Mortality Following Cord Blood Transplantation (CBT): A Matched Cohort Analysis Comparing Myeloablative Cord, Matched Unrelated, and Mismatched Unrelated Donor Transplants. , 2008 .
[8] M. Arcila,et al. Graft-Vs-Graft Immune Interaction Is the Likely Mechanism of Absolute Unit Dominance in Double Unit Cord Blood (DCB) Transplantation Using Patient DCB Grafts: An in Vivo but Not in Vitro Phenomenon , 2008 .
[9] S. Feig,et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. , 2008, Blood.
[10] S. Sumitran-Holgersson,et al. Novel Antibodies to the Donor Stem Cell Population CD34+/VEGFR-2+ Are Associated With Rejection After Hematopoietic Stem Cell Transplantation , 2008, Transplantation.
[11] R. Gress,et al. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. , 2008, Best practice & research. Clinical haematology.
[12] J. Rowe. Allografting in ALL: the net widens. , 2008, Blood.
[13] J. Wagner,et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. , 2007, Blood.
[14] J. Klein,et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study , 2007, The Lancet.
[15] M. Martelli,et al. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation , 2007, Current opinion in oncology.
[16] J. Serody,et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. , 2007, Blood.
[17] J. Wagner,et al. Double umbilical cord blood transplantation. , 2006, Current opinion in immunology.
[18] B. Rocha,et al. The Tower of Babel of CD8+ T‐cell memory: known facts, deserted roads, muddy waters, and possible dead ends , 2006, Immunological reviews.
[19] I. Bernstein,et al. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. , 2005, Blood.
[20] B. Rocha,et al. Homeostasis of T cell numbers: from thymus production to peripheral compartmentalization and the indexation of regulatory T cells. , 2005, Seminars in immunology.
[21] K. Cornetta,et al. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] Todd E DeFor,et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. , 2005, Blood.
[23] J. Wagner,et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.
[24] M. Labopin,et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.
[25] Mamoru Ito,et al. Competitive Repopulation Assay of Two Gene-Marked Cord Blood Units in NOD/SCID/γcnull Mice , 2004 .
[26] B. Rocha,et al. CD8 T cell memory. , 2004, Seminars in immunology.
[27] S. Riddell,et al. Molecules and mechanisms of the graft-versus-leukaemia effect , 2004, Nature Reviews Cancer.
[28] S. Chevret,et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. , 2003, Blood.
[29] J Wagner,et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.
[30] J. Falkenburg,et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. , 2000, Blood.
[31] J. Falkenburg,et al. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. , 2000, Blood.
[32] J. Adamson,et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Yang,et al. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. , 1990, The New England journal of medicine.
[34] W. Murphy,et al. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection , 1987, The Journal of experimental medicine.
[35] M. Epstein,et al. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. , 1984, Cellular immunology.
[36] B. Yeap,et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[37] Mamoru Ito,et al. Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice. , 2004, Molecular Therapy.
[38] T. Blankenstein,et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay , 2001, Nature Medicine.
[39] P. Musto,et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. , 1998, Haematologica.